Bayer: Science For A Better Life - research - Cancer

A deeper understanding of cancer opens new opportunities for treatment

Small steps towards winning the battle

Cancer specialist Professor Ronald M. Bukowski believes that the key to cancer therapy lies in molecular manipulation.

Molecular biology and genetic engineering are opening up fantastic possibilities; yet new methods always meet with fear and skepticism. Professor Ronald M. Bukowski, an oncologist at the Cleveland Clinic in Ohio, has been studying the molecular basis of cancer for many years. In the course of his work he has also tested Bayer’s active substance sorafenib.

Discovering the wonder of the human body

The true revolution unleashed by molecular biology, however, is not the arrival of new drugs but the possibility of understanding the processes that take place inside the human body. This has a far-reaching impact on research. The new information can be used to develop specific cancer therapies, for example. Individualized medicine benefits everyone. Patients, doctors, pharmaceutical companies and health services basically all have the same goal: to find an effective cure for dangerous diseases. Join Professor Bukowski for a look into the future of cancer therapy.